Currently pulmonary veins isolation becomes one of the approaches for invasive treatment of paroxysmal atrial fibrillation (AF). One of difficult and unexplored problems associated with this procedure is management of patients in postoperative period ...
A. V Tarasov +2 more
doaj
Propafenone is an antiarrhythmic that has been used for the treatment of tachiarrytmias in both adults and children. The aim of this study was to analyze the pharmacologic effect of a magistral suspension of propafenone, due to lack of an adequate ...
Osnaya,Héctor +5 more
core
Aims: Clinical trials have shown an increased risk of death in patients with recent myocardial infarction who received antiarrhythmic drugs such as flecainide, encainide or moricizine, especially in the presence of associated structural heart disease ...
Chen, Li Ying +7 more
core +1 more source
Pharmacological cardioversion of atrial fibrillation with intravenous and oral propafenone
The aim of the study was to evaluate the efficacy of intravenous and oral propafenone for termination of recent onset (
Lukoševičiūtė, Aldona +1 more
core
Propafenone Toxicity Presenting With Wide QRS and Transient Ventricular Dyskinesia. [PDF]
Araújo de Lucena L +3 more
europepmc +1 more source
Propafenone-mediated gap junctional uncoupling results from aberrant connexin-43 trafficking. [PDF]
Li E +4 more
europepmc +1 more source
Flecainide Provides Comparable Rhythm Control Efficacy to Repeat Radiofrequency Ablation in Patients with Paroxysmal Atrial Fibrillation After Failed Cryoballoon Ablation. [PDF]
Ardıç ML +5 more
europepmc +1 more source
Propafenone Overdose Presenting With Brugada Phenocopy, QRS Widening, and Ventricular Fibrillation. [PDF]
Xiong Q, Xie Y.
europepmc +1 more source
A Case of Propafenone Toxicity in the Setting of Dehydration and Acute Kidney Injury
Propafenone is a class 1C antiarrhythmic and is one of the first-line drugs used in the management of atrial fibrillation. Its toxicity is rare, yet potentially life-threatening.
Haddad, Enad, Collins, Matthew
core
Nutrient Availability Dictates Cancer Metabolism-Based Therapeutic Responses to Nononcology Drugs. [PDF]
Pyun WY +26 more
europepmc +1 more source

